Premium

Alternative Insight and Premium Journalism

Latest Articles

(Stefani Reynolds/Bloomberg)

The ‘Unhedgeable Risk’ Aristides Capital’s Founder Is Most Worried About

Michelle Celarier October 7, 2021

Dan Loeb, CEO of Third Point (David Paul Morris/Bloomberg)

Equities Drive Third Point

Stephen Taub October 6, 2021

Said Haidar (Christopher Goodney/Bloomberg)

Haidar Delivers 26 Percent Gain in Best Month Ever

Stephen Taub October 6, 2021

Michael Nagle/Bloomberg

Citadel Outshines the Multistrat Field in September

Stephen Taub October 5, 2021

Larry Robbins (Kholood Eid/Bloomberg)

Glenview Still Outperforming Despite Recent Setback

Stephen Taub October 5, 2021

Andreas Halvorsen, CEO of Viking Global. (Scott Eells/Bloomberg)

Viking Joins the Private Equity Party

Stephen Taub October 4, 2021

Michael Nagle/Bloomberg

Greenlight’s Back in the Red

Stephen Taub October 1, 2021

Andreas Gebert/Bloomberg

The Most Crowded Shorts Include Nikola, Workhorse, Lemonade, and Root

Michelle Celarier September 30, 2021

Michael Nagle/Bloomberg

Ventyx’s RX for Going Public

Stephen Taub September 30, 2021

(Krisztian Bocsi/Bloomberg)

Big Quarter for VC Investments

Stephen Taub September 29, 2021

(Andrew Harrer/Bloomberg)

Melvin Makes Big Move into Live Nation

Stephen Taub September 28, 2021

(Bigstock photo)

Tiger Global’s Next Big Deal

Stephen Taub September 28, 2021

Michael Nagle/Bloomberg

Hedge Funds Eye SPAC Mergers

Stephen Taub September 27, 2021

Dan Loeb, CEO of Third Point. (David Paul Morris/Bloomberg)

Third Point Boosts SentinelOne Stake

Stephen Taub September 24, 2021

Curaleaf is one of JW Asset Management's cannabis-related holdings. (Jeenah Moon/Bloomberg)

From Triple-Digit Gain to Double-Digit Loss

Stephen Taub September 23, 2021

Michael Nagle/Bloomberg

Tiger Global’s $6 Billion-Plus Payday

Stephen Taub September 22, 2021

(Tiffany Hagler-Geard/Bloomberg)

Hedge Funds Cheer Uber’s Surge

Stephen Taub September 21, 2021

A Ginkgo Bioworks facility in Boston. (Scott Eisen/Bloomberg)

Ginkgo Bioworks’ SPAC Success Is Good News for These Hedge Funds

Stephen Taub September 20, 2021

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-18 Login